Bloom is Off the Rose at UnitedHealth Group

By JEFF GOLDSMITH A Forty Year Growth Saga is Coming to an End After market close Wednesday April 16, UnitedHealth Group reported its First Quarter 2025 earnings. UNH missed their expected 1Q earnings by 9 cents a share, but the firm also lowered its full year 2025 earnings estimate by 12%. On Thursday opening, investors…

Read More

Merck KGaA’s Rare Tumor Strategy Takes Shape With $3.9B SpringWorks Acquisition

SpringWorks Therapeutics brings to Merck KGaA two FDA-approved drugs, both currently under regulatory review in Europe. Beyond their initial applications in rare tumors, these small molecules are also being studied as monotherapies and as part of combinations treatments for certain cancers. The post Merck KGaA’s Rare Tumor Strategy Takes Shape With $3.9B SpringWorks Acquisition appeared…

Read More

Value-Based Care Gets Real

The mandatory CMS TEAM program begins next year. Are you ready? As hospitals consider their options for addressing the mandate, here are some actions to consider. The post Value-Based Care Gets Real appeared first on MedCity News.

Read More